156 related articles for article (PubMed ID: 35784527)
1. Prolactin: The Third Hormone in Breast Cancer.
Schuler LA; O'Leary KA
Front Endocrinol (Lausanne); 2022; 13():910978. PubMed ID: 35784527
[TBL] [Abstract][Full Text] [Related]
2. Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.
Arendt LM; Rugowski DE; Grafwallner-Huseth TA; Garcia-Barchino MJ; Rui H; Schuler LA
Breast Cancer Res; 2011 Jan; 13(1):R11. PubMed ID: 21276249
[TBL] [Abstract][Full Text] [Related]
3. Prolactin Alters the Mammary Epithelial Hierarchy, Increasing Progenitors and Facilitating Ovarian Steroid Action.
O'Leary KA; Shea MP; Salituro S; Blohm CE; Schuler LA
Stem Cell Reports; 2017 Oct; 9(4):1167-1179. PubMed ID: 28919264
[TBL] [Abstract][Full Text] [Related]
4. Prolactin and endocrine therapy resistance in breast cancer: The next potential hope for breast cancer treatment.
Li Y; Kong X; Xuan L; Wang Z; Huang YH
J Cell Mol Med; 2021 Nov; 25(22):10327-10348. PubMed ID: 34651424
[TBL] [Abstract][Full Text] [Related]
5. Progesterone receptors (PR) mediate STAT actions: PR and prolactin receptor signaling crosstalk in breast cancer models.
Leehy KA; Truong TH; Mauro LJ; Lange CA
J Steroid Biochem Mol Biol; 2018 Feb; 176():88-93. PubMed ID: 28442393
[TBL] [Abstract][Full Text] [Related]
6. A favorable role of prolactin in human breast cancer reveals novel pathway-based gene signatures indicative of tumor differentiation and favorable patient outcome.
Hachim IY; Shams A; Lebrun JJ; Ali S
Hum Pathol; 2016 Jul; 53():142-52. PubMed ID: 26980025
[TBL] [Abstract][Full Text] [Related]
7. Prolactin does not cause breast cancer and may prevent it or be therapeutic in some conditions.
Goodman G; Bercovich D
Med Hypotheses; 2008; 70(2):244-51. PubMed ID: 17658223
[TBL] [Abstract][Full Text] [Related]
8. Drugs that affect the breast and lactation.
Dickey RP; Stone SC
Clin Obstet Gynecol; 1975 Jun; 18(2):95-111. PubMed ID: 1095275
[TBL] [Abstract][Full Text] [Related]
9. Stiff collagen matrices increase tumorigenic prolactin signaling in breast cancer cells.
Barcus CE; Keely PJ; Eliceiri KW; Schuler LA
J Biol Chem; 2013 May; 288(18):12722-32. PubMed ID: 23530035
[TBL] [Abstract][Full Text] [Related]
10. Triennial Lactation Symposium: Prolactin: The multifaceted potentiator of mammary growth and function.
Trott JF; Schennink A; Petrie WK; Manjarin R; VanKlompenberg MK; Hovey RC
J Anim Sci; 2012 May; 90(5):1674-86. PubMed ID: 22205663
[TBL] [Abstract][Full Text] [Related]
11. Global profiling of prolactin-modulated transcripts in breast cancer in vivo.
Sato T; Tran TH; Peck AR; Liu C; Ertel A; Lin J; Neilson LM; Rui H
Mol Cancer; 2013 Jun; 12():59. PubMed ID: 23758962
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy and lactation in relation to breast cancer risk.
Vorherr H
Semin Perinatol; 1979 Jul; 3(3):299-311. PubMed ID: 392771
[TBL] [Abstract][Full Text] [Related]
13. The role of prolactin and growth hormone in breast cancer.
Wennbo H; Törnell J
Oncogene; 2000 Feb; 19(8):1072-6. PubMed ID: 10713692
[TBL] [Abstract][Full Text] [Related]
14. Prolactin synergizes with canonical Wnt signals to drive development of ER+ mammary tumors via activation of the Notch pathway.
O'Leary KA; Rugowski DE; Shea MP; Sullivan R; Moser AR; Schuler LA
Cancer Lett; 2021 Apr; 503():231-239. PubMed ID: 33472091
[TBL] [Abstract][Full Text] [Related]
15. Prolactin cooperates with loss of p53 to promote claudin-low mammary carcinomas.
O'Leary KA; Rugowski DE; Sullivan R; Schuler LA
Oncogene; 2014 Jun; 33(23):3075-82. PubMed ID: 23873024
[TBL] [Abstract][Full Text] [Related]
16. Should prolactin be reconsidered as a therapeutic target in human breast cancer?
Goffin V; Touraine P; Pichard C; Bernichtein S; Kelly PA
Mol Cell Endocrinol; 1999 May; 151(1-2):79-87. PubMed ID: 10411322
[TBL] [Abstract][Full Text] [Related]
17. Involvement of prolactin in breast cancer: redefining the molecular targets.
Llovera M; Touraine P; Kelly PA; Goffin V
Exp Gerontol; 2000 Feb; 35(1):41-51. PubMed ID: 10705038
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy and lactation after breast cancer elevate plasma prolactin, do not shorten and may prolong survival.
Bercovich D; Goodman G
Med Hypotheses; 2009 Dec; 73(6):942-7. PubMed ID: 19632054
[TBL] [Abstract][Full Text] [Related]
19. Modeling prolactin actions in breast cancer in vivo: insights from the NRL-PRL mouse.
O'Leary KA; Shea MP; Schuler LA
Adv Exp Med Biol; 2015; 846():201-20. PubMed ID: 25472540
[TBL] [Abstract][Full Text] [Related]
20. Defining the role of prolactin as an invasion suppressor hormone in breast cancer cells.
Nouhi Z; Chughtai N; Hartley S; Cocolakis E; Lebrun JJ; Ali S
Cancer Res; 2006 Feb; 66(3):1824-32. PubMed ID: 16452244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]